LABFF vs PFE: Which Stock is Better?

Side-by-side comparison of Laboratorios Farmaceuticos Rovi, S.A./Adr and Pfizer Inc in 2026

Comparison Updated:

LABFF

Laboratorios Farmaceuticos Rovi, S.A./Adr

$90.61

PFE

Pfizer Inc

$27.56

Key Metrics Comparison

MetricLABFFPFEWinner
Market Cap$4.63B$154.84BPFE
P/E Ratio28.9520.01PFE
EPS (TTM)$3.13$1.36LABFF
Revenue Growth0.1%-0.0%LABFF
Gross Margin63.4%75.8%PFE

Analyze LABFF

Full quant analysis

Analyze PFE

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LABFF or PFE a better investment?

Comparing LABFF and PFE: Laboratorios Farmaceuticos Rovi, S.A./Adr has a market cap of $4.63B while Pfizer Inc has $154.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LABFF and PFE?

LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LABFF or PFE?

Based on P/E ratios, PFE trades at a lower multiple (20.0x vs 28.9x).

Which is growing faster: LABFF or PFE?

LABFF has higher revenue growth at 0.1% vs -0.0% for PFE.

Which company is more profitable: LABFF or PFE?

Pfizer Inc (PFE) has higher gross margins at 75.8% compared to 63.4% for LABFF.

Which is the larger company: LABFF or PFE?

Pfizer Inc (PFE) is larger with a market cap of $154.84B compared to $4.63B for LABFF.

Should I buy LABFF or PFE in 2026?

Both LABFF and PFE have investment merit. LABFF trades at $90.61 while PFE trades at $27.56. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LABFF and PFE stock?

Key differences: Market Cap ($4.63B vs $154.84B), P/E Ratio (28.9x vs 20.0x), Revenue Growth (0.1% vs -0.0%), Gross Margin (63.4% vs 75.8%).

Popular Stock Comparisons